LINC00922 binds to DNMT1, DNMT3A, and DNMT3B and is enriched in the promoter region of the downstream tumor suppressor NKD2, thereby inhibiting its expression through methylation, which ultimately activates the Wnt signaling pathway and promotes cancer progression (87). The gene discussed is DNMT3A; the disease is cancer.